Midline IV replacements under the microscope: a hospital study
NCT ID NCT07394296
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study tracks nearly 1,000 hospital patients who get a midline IV, a type of intravenous line used for treatments lasting up to 28 days. Researchers want to see how often these lines need to be replaced or removed early, and why. The goal is to help doctors choose the best IV device for each patient, reducing complications and improving care.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- What this could lead to
- If successful, this could help hospitals choose the right IV device for each patient, reducing unnecessary replacements and complications.
- What could go wrong
- This is an observational study, not a treatment trial, so it won't directly improve patient outcomes. Results may vary across hospitals and may not apply to all settings.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for IMPROVE THE MANAGEMENT OF MIDLINES AFTER PLACEMENT are added.
By submitting, you agree to our Terms of use
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Centre Hospitalier de Valenciennes
RECRUITINGValenciennes, 59300, France